Investors in Progenics Pharmaceuticals, Inc. (PGNX) saw new options become available this week, for the March 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PGNX options chain for the new March 22nd contracts and identified one put and one call contract of particular interest.The put contract at the $6.00 strike price has a current bid of 95 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $6.00, but will also collect the premium, putting the cost basis of the shares at $5.05 (before broker commissions). To an investor already interested in purchasing shares of PGNX, that could represent an attractive alternative to paying $6.67/share today.
First Week Of March 22nd Options Trading For Progenics Pharmaceuticals (PGNX)
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts